Concepedia

Sara E. Garwick-Coppens

SE

6

Publications

356

Citations

6

H-Index

2011

Active since

Affiliations

Nationwide Children's Hospital(Current)

The Ohio State University

Sara E. Garwick-Coppens is an author at Nationwide Children's Hospital specializing in medicine, transcriptional regulation, and gene expression.

Top concepts

Publications per year

2011–2021

6

Publications

6

RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy

Lindsay M. Wallace, Jian Liu, Jacqueline S. Domire et al. · Molecular Therapy · 2012 · 119 citations · Full text

AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD

Carlee R. Giesige, Lindsay M. Wallace, Kristin N. Heller et al. · JCI Insight · 2018 · 74 citations · Full text

Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4

Jocelyn O. Eidahl, Carlee R. Giesige, Jacqueline S. Domire et al. · Human Molecular Genetics · 2016 · 53 citations · Full text

, , +15

Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy

Nizar Y. Saad, Mustafa Al-Kharsan, Sara E. Garwick-Coppens et al. · Nature Communications · 2021 · 50 citations · Full text

RNA Interference Improves Myopathic Phenotypes in Mice Over-expressing FSHD Region Gene 1 (FRG1)

Lindsay M. Wallace, Sara E. Garwick-Coppens, Rossella Tupler et al. · Molecular Therapy · 2011 · 44 citations · Full text

Rows per page

1–5 of 6